Elkfork Partners’s MiMedx Group MDXG Stock Holding History

Elkfork Partners’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,122	Closed	-$77K	–	1021
2018 Q2	$77K	Hold	12,122	–	–	﹤0.01%	955
2018 Q1	$85K	Buy	12,122 +308	+3%	+$3.59K	﹤0.01%	957
2017 Q4	$149K	Buy	11,814 +1,782	+18%	+$21.7K	﹤0.01%	858
2017 Q3	$119K	Buy	10,032 +1,958	+24%	+$29K	﹤0.01%	865
2017 Q2	$121K	Buy	8,074 +3,894	+93%	+$52K	﹤0.01%	817
2017 Q1	$40K	Sell	4,180 -374	-8%	-$3.16K	﹤0.01%	942
2016 Q4	$40K	Buy	+4,554	New	+$40.9K	﹤0.01%	910

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Elkfork Partners's MDXG Position: Q3 2018 in Review

Elkfork Partners sold out of MiMedx Group (MDXG) in Q3 2018, closing a stake of 12,122 shares — an estimated $77K sold.

Elkfork Partners first reported a position in MDXG in Q4 2016 and held it in 7 quarters. The position peaked at $149K in Q4 2017. 186 funds tracked by Wall St. Rank hold MDXG as of Q3 2018.

Elkfork Partners reported no remaining MiMedx Group position as of Q3 2018 after selling out during the quarter.
Elkfork Partners sold 12,122 MiMedx Group shares in Q3 2018, an estimated $77K.
Elkfork Partners first reported a position in MiMedx Group in Q4 2016 and held it in 7 quarters.
Elkfork Partners's MiMedx Group position peaked at $149K in Q4 2017.
186 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2018.

Based on Elkfork Partners's 13F filing for Q3 2018, filed 14 Nov 2018.